Skip to content
HowShorted

VBI Vaccines, Inc. New short interest in 2021

In 2021, VBI Vaccines, Inc. New's disclosed short interest ran from 18.49% of shares outstanding on 15 Jan 2021 to 5.90% on 31 Dec 2021, a change of -12.59 percentage points. The year's high was 18.49% on 15 Jan 2021 and its low 5.90% on 31 Dec 2021, averaging 12.00% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.39 days on 28 May 2021. Full history: VBI Vaccines, Inc. New.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for VBI Vaccines, Inc. New in 2021

2021 in figures

Start of year
18.49% (15 Jan 2021)
End of year
5.90% (31 Dec 2021)
Change
-12.59 pp
High
18.49% (15 Jan 2021)
Low
5.90% (31 Dec 2021)
Average
12.00%
Highest days to cover
17.39 (28 May 2021)
SEC filings marked
8

Every report in 2021

VBI Vaccines, Inc. New short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 202118.49%9.27
29 Jan 202117.40%6.57
12 Feb 202116.33%3.51
26 Feb 202116.07%6.86
15 Mar 202117.14%8.4710-K filed, results (8-K)
31 Mar 202115.17%8.10
15 Apr 202115.49%14.76
30 Apr 202114.85%12.49
14 May 202115.20%12.5710-Q filed, results (8-K)
28 May 202113.87%17.39
15 Jun 202113.21%7.63
30 Jun 202110.73%5.91
15 Jul 202110.34%10.63
30 Jul 202111.02%14.86
13 Aug 202111.06%16.6310-Q filed, results (8-K)
31 Aug 20219.77%10.21
15 Sep 20218.97%9.14
30 Sep 20217.96%9.55
15 Oct 20217.75%14.30
29 Oct 20217.93%11.17
15 Nov 20218.08%11.0110-Q filed, results (8-K)
30 Nov 20217.90%6.58
15 Dec 20217.32%2.15
31 Dec 20215.90%5.82

See also: VBI Vaccines, Inc. New's full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.